U.S. General Merchandise and Department Stores Stock News

NYSE:PLD
NYSE:PLDIndustrial REITs

Prologis (PLD) Presses SEGRO Shareholders As Takeover Resistance Drags On

Prologis (NYSE:PLD) has taken its proposed all stock combination with SEGRO public, releasing a new presentation to SEGRO shareholders. The company is urging SEGRO investors to press their board to enter takeover talks, while SEGRO's board continues to resist the deal. This move shifts the discussion from private boardroom talks to a wider shareholder audience, highlighting Prologis' commitment to a public engagement campaign. Prologis enters this phase of the saga with its stock at $141.0...
NYSE:LNN
NYSE:LNNMachinery

Lindsay (LNN) Stock Still Looks Cheap Despite a 26% Slide

Lindsay stock is coming off a challenging stretch, with the share price down about 26% over 5 years, yet the current intrinsic value estimate from a Discounted Cash Flow (DCF) model points to meaningful upside compared with where the market is pricing it today. At the same time, earnings based multiples look roughly in line with peers, which sets up a tension between a seemingly cheap cash flow profile and a share price that does not screen as obviously mispriced on simpler metrics. Over 5...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Precigen (PGEN) In Focus As Russell Removal Tests Its Undervalued Narrative

Index removal puts Precigen stock in focus Precigen (PGEN) has been removed from several Russell value and small cap benchmarks, an index reshuffle that can prompt passive funds to rebalance and temporarily change trading volumes or pricing. See our latest analysis for Precigen. For context, Precigen's share price has a 30 day share price return of 55.74% and a year to date share price return of 29.91%, while the 1 year total shareholder return of 192.63% and 3 year total shareholder return...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Pagaya (PGY) Expands Upgrade Partnership Into Buy Now Pay Later For Travel

Pagaya Technologies and Upgrade have expanded their partnership to bring Pagaya’s AI-driven credit decisioning to Buy Now, Pay Later offerings. The collaboration targets BNPL solutions for travel merchants, broadening Pagaya’s reach beyond personal loans. The development highlights a move into new asset classes for Pagaya’s platform, with potential implications for its client mix and revenue sources. Pagaya Technologies (NasdaqCM:PGY) is drawing fresh attention as it extends its AI credit...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Opens East Asia Routes With First Air Premia Partnership

Southwest Airlines and Korean carrier Air Premia have entered into their first-ever interline partnership. The agreement connects Air Premia routes from South Korea with more than 120 destinations across the Southwest Airlines network. The partnership opens new East Asia connectivity for Southwest customers and expands options for travelers originating in South Korea. For investors watching Southwest Airlines, ticker NYSE:LUV, this partnership introduces an additional international angle to...
NYSE:WHD
NYSE:WHDEnergy Services

Cactus (WHD) Stock Looks Strong On Returns Yet Rich On Earnings

Cactus stock has delivered a solid 49.9% return over the past five years, yet current valuation checks suggest the shares are not an obvious bargain at recent levels. With the latest move putting the stock at US$53.73 and broader value indicators leaning expensive, investors are weighing whether the recent performance still leaves enough room for attractive future returns. Over the past five years, Cactus has returned 49.9%, which sets a relatively high bar for what investors might...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Monte Rosa Therapeutics (GLUE) Recast As A Growth Name As Valuation Questions Build

Monte Rosa Therapeutics (GLUE) is in focus after a broad reshuffle of its index affiliations, as the stock was added to several Russell growth benchmarks while being removed from multiple value oriented Russell indexes. See our latest analysis for Monte Rosa Therapeutics. The index reshuffle comes after a sharp run in Monte Rosa Therapeutics' share price, with a 30 day share price return of 41.53% and a year to date share price return of 57.15%, alongside a one year total shareholder return...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Personalis (PSNL) Stock Looks Rich Even After A Very Large Run

Personalis stock has delivered a very large 3 year gain, yet the valuation checks still lean expensive, which puts the recent share price strength in tension with what the broader numbers suggest about value. Over the past 3 years, Personalis has returned roughly 5x, which is a very large move that raises the bar for what the current share price needs to justify. Future revenue growth and the path to stronger, more consistent cash flows can support today’s valuation. However, execution risks...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Stock Still Looks Below Fair Value Today

Halliburton stock has delivered a 79.3% return over the past five years, and the current checks still suggest the shares lean cheap rather than fully priced in. With fresh contracts in Iraq and mixed short term trading, investors are weighing how much of the story is already reflected in the valuation. A 79.3% five year return points to solid longer term shareholder gains, raising the question of how much upside may already be captured in Halliburton's current price. The recent agreement to...
NYSE:DLX
NYSE:DLXCommercial Services

How Investors May Respond To Deluxe (DLX) Joining Russell 2000 Defensive and Value-Defensive Indices

In June 2026, Deluxe Corporation (NYSE: DLX) was added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, highlighting its classification as a smaller-cap company with more defensive, value-oriented characteristics. This dual index inclusion can influence how institutional investors view Deluxe, potentially affecting demand for the shares as index-tracking funds and quantitatively driven portfolios adjust their holdings. Next, we’ll examine how Deluxe’s...
NasdaqGS:CBC
NasdaqGS:CBCBanks

Is Central Bancompany’s Shift Into Russell Defensive Indices Reframing The Investment Case For CBC?

On 27 June 2026, Central Bancompany, Inc. was removed from the Russell 1000 Dynamic Index and added to the Russell 1000 Value-Defensive and Russell 1000 Defensive indices, reshaping its index footprint among large-cap US equities. This reclassification into defensive-oriented benchmarks may influence how institutional investors perceive the bank’s risk profile and adjust their portfolio allocations. Now we’ll explore how Central Bancompany’s shift into Russell 1000 defensive indices affects...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Company (DCI) Faces Soft Demand, Is It Still 9% Undervalued?

Donaldson Company (DCI) is back in focus after fresh analysis pointed to weak constant currency revenue growth, soft demand and declining returns on capital, raising questions around the stock’s underlying earnings power. See our latest analysis for Donaldson Company. Despite the recent concerns around Donaldson Company’s growth profile, the stock is trading at $87.68 and has eased in the short term, with the share price falling 2.1% over the last day and 1.6% over the past quarter. At the...
NYSE:WOR
NYSE:WORMachinery

Does Index Exit And Equity Grant Reshape the Bull Case For Worthington Enterprises (WOR)?

Worthington Enterprises, Inc. (NYSE: WOR) was removed from the Russell 2000 Dynamic Index on 27 June 2026, a change that can influence how index funds and benchmarked investors allocate capital to the stock. At the same time, a fresh restricted stock grant to director William Bradley Southern under the 2025 Equity Plan ties board compensation more closely to future company performance and governance continuity. We’ll now examine how Worthington’s removal from the Russell 2000 Dynamic Index...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

3 Promising Stocks Estimated To Be Up To 26.7% Below Intrinsic Value

In the last week, the United States market has stayed flat, yet over the past 12 months, it has risen by an impressive 18%, with earnings expected to grow at a similar rate annually in the coming years. In this context of steady growth and optimistic projections, identifying stocks that are trading below their intrinsic value can offer investors potential opportunities for capitalizing on undervalued assets.
NYSE:EL
NYSE:ELPersonal Products

3 Insider-Owned Growth Companies To Watch Now

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings forecasted to grow by 18% annually. In this environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests with shareholders.
OTCPK:PDPT.F
OTCPK:PDPT.FLogistics

Lianhe Sowell International Group And 2 Other Promising Penny Stocks To Watch

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 18%, with earnings expected to grow at a similar rate in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but they still offer potential for growth when backed by strong financials. These smaller or newer companies can provide a mix of affordability and opportunity that larger firms sometimes miss.
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

3 Reliable Dividend Stocks Offering At Least 3% Yield

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 18%, with earnings expected to grow by an additional 18% annually. In this context of steady growth and potential future gains, identifying reliable dividend stocks offering at least a 3% yield can be an effective strategy for investors seeking both income and stability.
NYSE:KSS
NYSE:KSSMultiline Retail

Is Kohl's (KSS) A Bargain As Its Credit Amendment Extends Funding Runway?

Why Kohl's Credit Agreement Amendment Matters for Stockholders Kohl's (KSS) recently amended its revolving credit facility with Wells Fargo, extending the maturity to June 30, 2031 and revising pricing, availability triggers, and the borrowing base, including new treatment for in transit inventory. This financing move lands against a backdrop of disappointing same store sales over the past two years and limited operating margin profitability. Together, these factors have raised questions...
NasdaqGS:ACT
NasdaqGS:ACTDiversified Financial

Does Enact Holdings’ (ACT) Earnings Beat Mask a Stagnating Premium Engine in Challenging Housing Markets?

In early July 2026, Genworth Financial said President and CEO Thomas J. McInerney would take a temporary health-related leave, with CFO Jerome Upton stepping in as interim chief executive, while Enact Holdings reported first-quarter 2026 earnings that beat earnings-per-share forecasts but came in slightly light on revenue. Analysts highlighted that Enact’s stagnant net premiums earned over the past five years and flat near-term sales expectations may limit expansion, especially as mortgage...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

Chord Energy (CHRD) Is Up 9.4% After Strait of Hormuz Supply Scare Lifted Oil Prices

In early July 2026, reports of attacks on commercial ships near the Strait of Hormuz and renewed U.S.–Iran tensions pushed global oil prices higher, lifting sentiment across oil and gas producers such as Chord Energy. The episode underscores how quickly geopolitical shocks in critical shipping lanes can alter the revenue outlook for shale-focused operators reliant on crude benchmarks. With oil prices recently boosted by heightened Strait of Hormuz tensions, we’ll examine how this supply...
NasdaqGM:MKTW
NasdaqGM:MKTWCapital Markets

MarketWise Stock and 2 More Picks for Investors Watching Volatility and AI

Geopolitics, oil price swings, and mixed signals from the Federal Reserve have pushed volatility back to the forefront, and that can quickly reshape trading activity across exchanges, options markets, and volatility linked products. Instead of trying to forecast the next headline, it can help to look at which stocks are directly exposed to this surge in hedging and trading demand linked to the latest war escalation between the United States and Iran, the spike in crude oil, and the strength...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

Does EverCommerce’s (EVCM) Value Index Inclusion Reframe Its Recurring Revenue And Profitability Story?

EverCommerce Inc. (NasdaqGS:EVCM) was added in June 2026 to several Russell value benchmarks, including the Russell 2000, 2500, 3000, Small Cap Composite, and 3000E Value indices. This broad inclusion across multiple Russell value indices highlights how EverCommerce is now being grouped with value-oriented small and mid-cap peers in key benchmarks tracked by institutional investors. Next, we’ll examine how EverCommerce’s broad Russell value index inclusion may influence its investment...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Vera Therapeutics (VERA) Wins FDA Approval For TRUTAKNA, Is The Stock Fully Priced?

Vera Therapeutics (VERA) is in focus after the US Food and Drug Administration granted accelerated approval for TRUTAKNA, the company’s first commercial product for adults with primary IgA nephropathy at risk for disease progression. See our latest analysis for Vera Therapeutics. The FDA approval of TRUTAKNA comes after a strong run for Vera Therapeutics, with the 1 year total shareholder return of 74.25% contrasting with a year to date share price return that is down 12.73% and shorter term...
NYSE:AMN
NYSE:AMNHealthcare

Is AMN’s AI Staffing Push and Softening Demand Altering The Investment Case For AMN Healthcare Services (AMN)?

In June 2026, AMN Healthcare Services scheduled an August 6 conference call to discuss its second-quarter 2026 results and third-quarter outlook, while also announcing new commercial and people leadership appointments and highlighting momentum in its Managed Services Program and AI-driven staffing tools. At the same time, investors have been weighing this operational progress against concerns about softening traveler demand, declining earnings per share, and a weaker return on invested...